Leukemia
Showing all 16 results
-
Atriance (nelarabine) for injection
Read more -
BLINCYTO (blinatumomab) for injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
BOSULIF (bosutinib) tablets
Read more -
ICLUSIG (ponatinib) tablets for oral use. Initial U.S. Approval: 2012
Read more -
JAYPIRCA (pirtobrutinib)
Read more -
JYLAMVO (methotrexate) oral
Read more -
ONUREG (azacitidine) tablets, for oral use. Initial U.S. Approval: 2004
Read more -
RYLAZE (asparaginase erwinia chrysanthemi (recombinant) rywn) injection
Read more -
SCEMBLIX (asciminib) tablets
Read more -
Tasigna (nilotinib) Capsules Initial U.S. Approval: 2007
Read more -
TIBSOVO (ivosidenib tablets), for oral use. Initial U.S. Approval: 2018
Read more -
VANFLYTA (quizartinib)
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
VYXEOS (daunorubicin and cytarabine) liposome for injection
Read more -
XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more
